Cigna Group $CI Shares Sold by J. Safra Sarasin Holding AG

Key Points

• J. Safra Sarasin Holding AG drastically reduced its holdings in Cigna Group by 94.6% during the second quarter, leaving it with only 936 shares valued at approximately $309,000.
• Insider Nicole S. Jones sold 28,526 shares of Cigna Group stock for about $8.56 million, marking a significant reduction of 52.66% in her holdings.
• Cigna Group reported a 11% year-over-year revenue increase to $67.13 billion for the last quarter, exceeding analyst expectations and posting an EPS of $7.20.

J. Safra Sarasin Holding AG lowered its position in shares of Cigna Group (NYSE:CI - Free Report) by 94.6% in the second quarter, according to the company in its most recent filing with the SEC. The firm owned 936 shares of the health services provider's stock after selling 16,486 shares during the quarter. J. Safra Sarasin Holding AG's holdings in Cigna Group were worth $309,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also modified their holdings of CI. Brighton Jones LLC lifted its holdings in shares of Cigna Group by 9.3% in the 4th quarter. Brighton Jones LLC now owns 3,736 shares of the health services provider's stock valued at $1,032,000 after buying an additional 318 shares during the period. NBC Securities Inc. acquired a new position in shares of Cigna Group in the 1st quarter valued at about $123,000. RFG Advisory LLC acquired a new position in shares of Cigna Group in the 1st quarter valued at about $233,000. Hennion & Walsh Asset Management Inc. lifted its holdings in shares of Cigna Group by 13.5% in the 1st quarter. Hennion & Walsh Asset Management Inc. now owns 1,212 shares of the health services provider's stock valued at $399,000 after buying an additional 144 shares during the period. Finally, Signal Advisors Wealth LLC lifted its holdings in shares of Cigna Group by 106.2% in the 1st quarter. Signal Advisors Wealth LLC now owns 1,827 shares of the health services provider's stock valued at $601,000 after buying an additional 941 shares during the period. Institutional investors and hedge funds own 86.99% of the company's stock.

Insider Buying and Selling

In other Cigna Group news, insider Nicole S. Jones sold 28,526 shares of the business's stock in a transaction that occurred on Friday, August 15th. The stock was sold at an average price of $300.00, for a total transaction of $8,557,800.00. Following the completion of the sale, the insider directly owned 25,648 shares in the company, valued at approximately $7,694,400. The trade was a 52.66% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 0.70% of the company's stock.

Cigna Group Price Performance

NYSE:CI opened at $311.24 on Friday. Cigna Group has a 12 month low of $256.89 and a 12 month high of $358.88. The stock has a 50 day moving average of $292.41 and a two-hundred day moving average of $309.73. The company has a current ratio of 0.71, a quick ratio of 0.71 and a debt-to-equity ratio of 0.65. The firm has a market cap of $83.08 billion, a P/E ratio of 16.99, a price-to-earnings-growth ratio of 0.91 and a beta of 0.45.

Cigna Group (NYSE:CI - Get Free Report) last posted its quarterly earnings data on Thursday, July 31st. The health services provider reported $7.20 EPS for the quarter, topping the consensus estimate of $7.15 by $0.05. Cigna Group had a return on equity of 18.80% and a net margin of 1.92%.The company had revenue of $67.13 billion during the quarter, compared to analyst estimates of $62.61 billion. During the same period in the previous year, the business earned $6.72 EPS. Cigna Group's quarterly revenue was up 11.0% on a year-over-year basis. Cigna Group has set its FY 2025 guidance at 29.600- EPS. On average, analysts expect that Cigna Group will post 29.77 earnings per share for the current fiscal year.

Cigna Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, September 18th. Shareholders of record on Thursday, September 4th were paid a dividend of $1.51 per share. This represents a $6.04 annualized dividend and a yield of 1.9%. The ex-dividend date was Thursday, September 4th. Cigna Group's payout ratio is 32.97%.

Analysts Set New Price Targets

CI has been the subject of several analyst reports. TD Cowen raised Cigna Group to a "strong-buy" rating in a report on Monday, June 23rd. Truist Financial set a $375.00 price objective on Cigna Group in a report on Tuesday, September 2nd. Guggenheim reissued a "buy" rating and issued a $350.00 price objective (down previously from $388.00) on shares of Cigna Group in a report on Monday, August 4th. Cantor Fitzgerald reaffirmed an "overweight" rating and issued a $365.00 price target on shares of Cigna Group in a report on Tuesday, August 26th. Finally, Royal Bank Of Canada reaffirmed an "outperform" rating and issued a $371.00 price target on shares of Cigna Group in a report on Thursday, June 26th. Two analysts have rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat.com, Cigna Group has a consensus rating of "Moderate Buy" and a consensus target price of $371.81.

Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.